drugset / Trial / NCT05057923
The Development of a COVID19 Oral Vaccine Consisting of Bacillus Subtilis Spores
Non-randomizedParallel-groupOpen-labelBasic science
Summary
This is a study trial to assess the effectiveness of the immune response stimulated by the genetically engineered Bacillus subtilis which express and display Spike protein of the SARS-COV2 on the spore coat.
Timeline
- Start
- 2021-07-10
- Primary completion
- 2021-10-20
- Completion
- 2021-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bacillus subtilis | Vaccine | 1e+10 unknown | Oral |
| Subject | Bacillus subtilis | Vaccine | 1e+11 unknown | Oral |